Literature DB >> 11942932

Do cenesthesias and body image aberration characterize a subgroup in schizophrenia?

Frank Röhricht1, Stefan Priebe.   

Abstract

OBJECTIVE: To identify and characterize a subgroup of schizophrenia patients with marked and dominating bodily sensations (cenesthesias and body image aberration).
METHOD: We assessed cenesthesias and different aspects of body image aberration systematically along with common (general, positive and negative symptoms) and ego-psychopathology in 60 patients with acute paranoid schizophrenia. Cluster analysis was applied to identify subgroups. Psychopathology scores of the clusters were compared at admission and after 2 weeks of hospital treatment.
RESULTS: One of the three clusters comprised of 14 patients (23.3%) with marked disturbances of body experience (underestimation of lower extremities, desomatization, boundary loss and diminution). The subgroup was further characterized by significantly higher ego-psychopathology scores at admission. Some of the differences held true over a 2-week period.
CONCLUSION: The findings from the present study suggest that cenesthesias and body image aberration might represent an additional dimension of psychopathology that might be used for defining a nosological subtype of schizophrenia.

Entities:  

Mesh:

Year:  2002        PMID: 11942932     DOI: 10.1034/j.1600-0447.2002.1107.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

Review 1.  The demystification of autoscopic phenomena: experimental propositions.

Authors:  Christine Mohr; Olaf Blanke
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

2.  Self-monitoring in schizophrenia: Weighting exteroceptive visual signals against self-generated vestibular cues.

Authors:  Kiley Seymour; Mariia Kaliuzhna
Journal:  Schizophr Res Cogn       Date:  2022-05-14

3.  Deficits in agency in schizophrenia, and additional deficits in body image, body schema, and internal timing, in passivity symptoms.

Authors:  Kyran T Graham; Mathew T Martin-Iverson; Nicholas P Holmes; Assen Jablensky; Flavie Waters
Journal:  Front Psychiatry       Date:  2014-09-10       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.